There\u2019s a story so absurd on its surface that it deserved to be everywhere last week. Between everything else competing for attention, it wasn\u2019t.<\/p>\n
It involves a Swedish medical researcher, a fictional eye disease, two deliberately fake academic papers, and the moment four of the biggest AI companies on the planet fell for all of it.<\/p>\n
The papers thanked Starfleet Academy. They credited funding to the Professor Sideshow Bob Foundation and the University of Fellowship of the Ring. And buried in the text of the research itself, in plain language, the papers stated that the entire thing was made up.<\/p>\n
None of that stopped Microsoft\u2019s Copilot<\/strong>, Google\u2019s Gemini<\/strong>, OpenAI\u2019s ChatGPT<\/strong>, or Perplexity<\/strong> from presenting the fake disease to users as real medicine \u2014 complete with symptoms, causes, prevalence rates, and specialist referrals.<\/p>\n The disease is called bixonimania. It does not exist. The experiment that created it began in early 2024 \u2014 and for nearly two years, the fake condition circulated through AI systems largely unnoticed. Last week, Nature<\/em><\/a> revealed the full story behind one of the most elaborate AI stress tests ever conducted.<\/p>\n This researcher created a fictional illness, and fake studies funded by the Professor Sideshow Bob Foundation and University of the Fellowship of the Ring and the Galactic Triad.<\/p>\n LLMs warned people the illness was real.https:\/\/t.co\/knCxx00VAZ<\/a><\/p>\n \u2014 nature (@Nature) April 7, 2026<\/a><\/p>\n<\/blockquote>\n Almira Osmanovic Thunstr\u00f6m, a medical researcher at the University of Gothenburg, launched the experiment in early 2024. In an interview with Nature<\/em>, she explained her reasoning: if she planted a fake medical condition in the ecosystem that AI systems feed on, would they swallow it?<\/p>\n She invented bixonimania \u2014 a fictional eye condition described as eyelid discoloration and soreness caused by blue light from screens. She chose the name deliberately. No legitimate eye condition would ever carry the suffix \u201cmania.\u201d That\u2019s a psychiatric term. Any physician who encountered it would know immediately that something was wrong.<\/p>\n Then she made it even harder to miss. The lead author was a fabricated researcher named Lazljiv Izgubljenovic, affiliated with Asteria Horizon University in Nova City, California. The university doesn\u2019t exist. The city doesn\u2019t exist. One paper stated outright that \u201cfifty made-up individuals\u201d were recruited for the study. She uploaded two preprints<\/a>, sat back, and waited.<\/p>\n It took weeks.<\/p>\n By April 2024, according to Nature<\/em>\u2018s investigation, the major AI systems had found the papers and started treating bixonimania as settled medical knowledge.<\/p>\n Microsoft\u2019s Copilot described bixonimania as \u201cindeed an intriguing and relatively rare condition.\u201d Google\u2019s Gemini went further, informing people it was caused by excessive blue light exposure and advising them to visit an ophthalmologist. Perplexity cited a specific prevalence rate \u2014 one in 90,000 people \u2014 as though the data behind that number were real. ChatGPT began fielding user symptoms and telling people whether their complaints matched the condition.<\/p>\n None of these systems flagged the Starfleet Academy acknowledgment. None caught the Sideshow Bob Foundation funding credit. None paused at the sentence that said the entire paper was fabricated. They processed the formatting \u2014 academic preprint, clinical language, structured methodology \u2014 and treated it as credible.<\/p>\n The fake disease wasn\u2019t just absorbed. It was elaborated on, expanded, and served to millions of users as real medical guidance.<\/p>\n If the experiment had ended with chatbots repeating a fake diagnosis, it would have been a cautionary tale with a punchline. It didn\u2019t end there.<\/p>\n Researchers at the Maharishi Markandeshwar Institute of Medical Sciences and Research in India published a peer-reviewed paper in Cureus<\/em>, a journal under the Springer Nature umbrella, that cited one of the bixonimania preprints as a legitimate source. Their paper described the fake condition as \u201can emerging form of periorbital melanosis linked to blue light exposure\u201d and noted that further research was underway.<\/p>\n The implication, according to Osmanovic Thunstr\u00f6m, is that some researchers may be letting AI compile their citations without verifying what those citations actually say. The fake disease didn\u2019t just fool chatbots. It entered the published scientific record through human hands.<\/p>\n\n
A Trap Designed to Be Caught<\/h2>\n
The Machines Didn\u2019t Blink<\/h2>\n
![\"Asteria](\"https:\/\/wealthofgeeks.com\/wp-content\/uploads\/2026\/04\/Untitled-design-2026-04-13T151505.068.jpg\"\/ "\\"Asteria")
![\"ChatGPT\"](\"https:\/\/wealthofgeeks.com\/wp-content\/uploads\/2026\/04\/Untitled-design-2026-04-13T151505.068.jpg\" "\\"ChatGPT\\"")
<\/p>\nThen It Jumped<\/h2>\n